Cdsco News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cdsco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cdsco Today - Breaking & Trending Today

Drug export regime recast to soothe quality concerns

Apart from tightening the approvals process for pharmaceutical products meant for overseas markets, the government’s efforts are also directed at strengthening drug exports ....

Republic Of , Sudarshan Jain , Daarab Patel , Abbott Digene , India Central Drugs Standard Control Organisation , Indian Drugs Manufacturers Association , Indian Pharmaceutical Alliance , Drug Administration , World Health Organization , India Pharmaceutical Export Promotion Council , Drug Administration Of Vietnam , Pharmaceutical Product , Central Drugs Standard Control Organisation , Drugs Controller General , Dabilife Pharma , Mint Explainer , Indian Pharmaceutical , Pharmaceutical Export Promotion Council , Test License , Indian Drugs Manufacturers , Drug Exports , Pharmaceutical Exports , Drug Safety Concerns , Cough Syrup ,

Regulator revokes state licensors' power to issue NOC for drug exports

India s drug regulator withdraws state licensing authorities NOC issuance power for export of unapproved drugs due to substandard products overseas. Industry to reapply via zonal offices online from May 15. Contaminated cough syrups linked to acute kidney injuries in Gambian children. ....

New Delhi , United States , Central Drugs Standards Control Organisation , Union Territories , Maiden Pharmaceuticals , United States Centers For Disease , United States Centers , Disease Control , Drug Regulator , Contaminated Drugs , Indian Drugs , Banned Drugs , Substandard Drugs , Health Concerns ,

insulin: Sanofi introduces diabetes drug Soliqua in India

Sanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 receptor agonist lixisenatide. The medication is available at a therapy cost of Rs 1,850 per pen and is indicated for adults with obesity and type 2 diabetes to improve glycemic control. ....

Sanofi India , Diabetes Drug , Glycemic Control , Central Drugs Standard Control Organization , Cyrus Aibara ,

Despite SC intensifying its focus on misleading ads, amendment to curb fake ads by drug cos delayed since 2020

Supreme Court addresses misleading ads, pending amendments to DMR(OA) Act since Feb 2020 with Union health ministry. Proposed changes aim to enhance penalties for prohibited drug ads. Complaints against Patanjali under DMRA. ....

Union Health Ministry , Supreme Court , Consumer Affairs Department , Central Drugs Standard Control Organisation , Ayush Ministry , Broadcasting Ministry , Magic Remedies , Objectionable Advertisements , Consumer Affairs , Cosmetics Act , Prime Minister , Misleading Ads , Drug And Magic Remedies Act ,

Government issues code to check unethical drug promotion

The code prohibits pharma companies from organising overseas workshops for healthcare professionals or providing them with accommodations, extravagant meals, or financial incentives ....

Ethics Committee For Pharma Marketing Practices , Uniform Code , Pharmaceutical Marketing Practices , Continuing Medical Education , Continuing Professional Development , Pharma Marketing , Pharma Manufacturing , Department Of Pharmaceuticals ,